Key result
Pharmacist-physician collaboration reduces SBP by ~8 mmHg, outperforming pharmacist-led interventions.
Why the study?
Effective intervention is crucial for improving blood pressure control and adherence, prompting an evaluation of the effectiveness of pharmacist-physician collaboration compared with pharmacist-led interventions.
Do pharmacist-physician collaboration and pharmacist-led interventions reduce blood pressure in patients with hypertension?
Meta-Analysis (n=4,387)
Do pharmacist-physician collaboration and pharmacist-led interventions reduce blood pressure in patients with hypertension?
Effect estimate: MD -8.22 (95% CI -11.01; -5.42)
p-value: p=<0.01
Both pharmacist-physician collaboration and pharmacist-led interventions are effective for blood pressure control, with collaborative care showing greater effectiveness.
Supports pharmacist-physician collaboration for hypertension control; confirms superiority over pharmacist-led care in meta-analysis.
Effective intervention is a significant component in the improvement of blood pressure control and patient adherence. Blood pressure control includes different self-monitoring techniques, mobile health monitoring, or healthcare professionals’ interventions. This study aims to compare, analyze, and interpret the effectiveness of pharmacist-physician collaboration and pharmacist- led interventions. Meta-analysis was performed using MEDLINE via PubMed, EMBASE, EBSCO, Web of Science, Scopus, and the Cochrane Library databases between 2008-2018. Of the 51 relevant systematic reviews identified, 15 were of sufficient quality and included in the data synthesis. The breakdown of the 15 included 7 (n=2026) pharmacist and 8 pharmacist-physician interventions (n=2361). The impact of pharmacist-physician collaboration and pharmacist-led interventions on Systolic Blood Pressure was –8.22 (–11.01; –5.42) (P<0.01) and –7.68 (–9.30; –6.06) (P=0.35), respectively. On the other hand, similar correlation for Diastolic Blood Pressure for the impact of pharmacist-physician collaboration and pharmacist-led interventions was –3.55 (–4.54; –2.55) (P=0.49) and –2.58 (–3.76; –1.39) (P=0.24), respectively. These results suggest that both interventions are effective for blood pressure control. However, when two meta-analyses were compared, it was found that pharmacist-physician collaboration was more effective than pharmacist-led interventions. This finding highlights the importance of multidisciplinary approaches during blood pressure control procedures. When a holistic view is considered; especially cost-effectiveness, future studies must be diversified to encompass a broader context and impact analysis.
No takes yet. Share an insight, caveat, or question.
Memişoğlu et al. (2021) conducted a meta-analysis in Hypertension (n=4,387). Pharmacist-physician collaboration and pharmacist-led interventions vs. Control group was evaluated on Systolic Blood Pressure (SBP) reduction (pharmacist-physician collaboration) (MD -8.22, 95% CI -11.01; -5.42, p=<0.01). Pharmacist-physician collaborative interventions significantly reduced systolic blood pressure by 8.22 mmHg compared to control, proving more effective than pharmacist-led interventions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: